Suspension of pump insulin during hypoglycaemia is safe 17 May 2012 0 comments Automatic cessation of insulin delivery from a pump in response to low blood glucose levels is safe and unlikely to be associated with adverse outcomes, a trial in Perth has concluded.
Few benefits from continuing metformin when insulin started 26 Apr 2012 0 comments There is very little evidence to support the recommended – and widely practised – continuation of metformin once insulin is commenced in patients with type 2 diabetes, according to a new…
Metformin reduces Parkinson’s risk in diabetes 26 Apr 2012 0 comments Untreated type 2 diabetes doubles the incidence of Parkinson’s disease but the risk is reduced by sulfonylureas and eliminated by metformin, a large epidemiological study has concluded.
Sleeve gastrectomy better than medication in obese type 2 diabetics 19 Apr 2012 0 comments The role of bariatric surgery in morbidly obese patients with type 2 diabetes has been further supported by a study showing laparoscopic sleeve gastrectomy durably resolved diabetes in 80% of cases.
Geelong cohort validated as reference point for osteoporosis diagnosis 12 Apr 2012 0 comments The use of a cohort of Geelong women to establish the population norm for bone mineral density – the basis for a diagnosis of osteoporosis in Australia – has been validated by comparative study of…
Unexpected results from flexible diet in adolescents with diabetes 5 Apr 2012 0 comments Switching adolescents with type 1 diabetes from a prescriptive diet to flexible meals and insulin doses unexpectedly leads to worse glycaemic control but better weight status, a pilot study at…
Caution needed with diabetes and H. pylori link 23 Feb 2012 0 comments Although H. pylori infection may increase the risk of type 2 diabetes, there is no justification for screening, Australian experts say.
Cochrane reviews bone agents in breast cancer 23 Feb 2012 0 comments A Cochrane review by Australian oncologists has quantified the benefits of bisphosphonates in patients with breast cancer and bone metastases.
Clinicians call for urgent action to reduce brand name confusion 8 Dec 2011 0 comments Leading Australian clinicians have called for urgent action to highlight the active ingredients on medicines on packaging in order to improve safety and reduce confusion by both patients and…
Autoimmune diseases magnify thromboembolism risk seven-fold 1 Dec 2011 0 comments All autoimmune diseases substantially increase the risk of pulmonary embolism and should be considered as hypercoagulable disorders which may benefit from preventive therapy, a new study has…